Surmodics, Inc.
SRDXNASDAQHealthcare
$42.98
+$0.15(+0.35%)
Market Cap$614511837
P/E Ratio—
52W High$43.0048
52W Low$25.87
Surmodics, Inc. (SRDX) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · SRDX · as of 2026-06-08
Financial statements
Revenue · Gross Profit · Net Income
| Breakdown | 2024-09 | 2023-09 | 2022-09 | 2021-09 | 2020-09 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $0.13B | $0.13B | $0.10B | $0.11B | $0.09B |
| Cost of Revenue | $0.03B | $0.07B | $0.07B | $0.06B | $0.07B |
| Gross Profit | $0.09B | $0.06B | $0.03B | $0.04B | $0.03B |
| Gross Margin %(computed) | 73.81% | 46.03% | 29.01% | 39.21% | 30.95% |
| Operating Expenses | |||||
| R&D Expenses | $0.01B | $0.01B | $0.01B | $0.05B | $0.05B |
| G&A Expenses | $0.00B | $0.00B | $0.05B | $0.03B | $0.03B |
| Total Operating Expenses | $0.10B | $0.10B | $0.05B | $0.08B | $0.03B |
| Operating Income | ($0.01B) | $0.01B | ($0.02B) | $0.01B | ($0.00B) |
| Operating Margin %(computed) | -4.48% | 3.88% | -22.11% | 6.38% | -1.32% |
| Interest Income | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Interest Expense | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Income Before Tax | ($0.01B) | $0.00B | ($0.02B) | $0.01B | ($0.00B) |
| Income Tax Expense | $0.00B | $0.00B | $0.00B | $0.00B | ($0.00B) |
| Net Income | ($0.01B) | ($0.00B) | ($0.03B) | $0.00B | $0.00B |
| Net Margin %(computed) | -9.15% | -1.16% | -27.29% | 4.03% | 1.18% |
| Per Share & EBITDA | |||||
| EPS (Basic) | $-0.82 | $-0.11 | $-1.96 | $0.31 | $0.08 |
| Wtd Avg Shares | 0.01B | 0.01B | 0.01B | 0.01B | 0.01B |
| EBITDA | $0.00B | $0.02B | ($0.01B) | $0.01B | $0.01B |
| EBITDA Margin %(computed) | 3.75% | 11.43% | -12.23% | 13.96% | 6.26% |
Data source: Financial Modeling Prep · Last updated: 2026-06-08 · USD · B
Explore more Surmodics, Inc. data
About Surmodics, Inc. (SRDX) Income Statement
Surmodics, Inc. (SRDX) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2024, SRDX reported revenue of $0.13B, gross profit of $0.09B (gross margin 73.81%), and net income of ($0.01B) — a net profit margin of -9.15%.
Frequently asked questions
SRDX · 4 questionsSurmodics, Inc. (SRDX) reported revenue of $0.13B for 2024, down 4.9% year-over-year.
SRDX revenueSRDX salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08